ArticleFrontiers in pharmacology2022

Dihydromyricetin ameliorates osteogenic differentiation of human aortic valve interstitial cells by targeting c-KIT/interleukin-6 signaling pathway.

Shaoshao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.